Xenon Pharmaceuticals Inc.
XENE
$55.23
-$2.67-4.61%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index
Headlines
3/13/2026
-
Fool.com Headlines
3/13/2026
-
Ticker Report
3/12/2026
-
TipRanks Financial Blog
3/12/2026
-
Globe Newswire
3/12/2026
-
MarketBeat
3/12/2026
-
MarketBeat
3/12/2026
-
Simply Wall St
3/12/2026
-
Tickeron - Stocks
3/12/2026
-
Ticker Report
3/12/2026
-
MarketBeat
3/12/2026
-
MarketBeat
3/12/2026
-
MarketBeat
3/12/2026
-
MarketBeat
3/11/2026
-
MarketBeat
3/11/2026
-
Ticker Report
3/11/2026
-
TipRanks Financial Blog
3/11/2026
-
Seeking Alpha - Healthcare
3/11/2026
-
SeekingAlpha.com: All News
3/11/2026
-
TipRanks Financial Blog
3/11/2026
-
Globe Newswire
3/11/2026
-
Simply Wall St
3/10/2026
-
Zacks Investment Research
Xenon Pharmaceuticals (NASDAQ:XENE) Stock Price Expected to Rise, Wells Fargo & Company Analyst Says
3/10/2026
-
Ticker Report
Xenon Pharmaceuticals (NASDAQ:XENE) Stock Price Expected to Rise, Wells Fargo & Company Analyst Says
3/10/2026
-
MarketBeat
3/10/2026
-
Ticker Report
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Thursday, February 26, 2026
Period Date
Wednesday, December 31, 2025
Next Filing
Week of May 11 and 15 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
604 484 3300
Address
200-3650 Gilmore Way
Burnaby, BC V5G 4W8
Burnaby, BC V5G 4W8
Country
Year Founded
Business Description
Sector
Xenon Pharmaceuticals Inc., a neuroscience-focused biopharmaceutical company, engages in the discovery, development, and delivery of therapeutics to treat patients with neurological and...
more